News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

New deal hopes to increase IVF success

New deal hopes to increase IVF success

Couples having fertility treatment may in the near future benefit from a technology developed by biotechnology company KODE Biotech Limited, an AUT University partner institution.

KODE Biotech signed an agreement this week with Olso Stock Exchange-listed Danish company MediCult a/s giving them exclusive global rights to KODE Biotech's Assisted Reproduction Technologies (ART) applications.

KODE Biotech works in collaboration with the AUT's Biotechnology Research Institute. It has an active research team of 14 people and has developed a substantial intellectual property portfolio based on KODE technology.

This novel technology harmlessly attaches molecules onto cells, ranging from red blood cells to embryos. It has multiple applications in medical therapeutics and diagnostics.

KODE Biotech's Chief Executive Officer Peter Bradley says the partnership between them and Medicult a/s ensures further development and ultimately its conversion into products for ART applications hopefully within four-five years.

"We are looking forward to working with MediCult and developing products that will bring meaningful benefits to ART customers," says Mr Bradley.

Although several new techniques in recent years have been implemented to increase pregnancy rates through IVF, the chance for a couple to take home a baby after one IVF treatment is still on average only 25%.

"If our early research can be shown to produce favourable outcomes in human clinical trials, this technology will further improve pregnancy and baby-take-home rates and will be applicable within standard IVF and IVM therapies," says Mr Bradley.

KODE Biotech's work was supported by a Technology for Business Growth grant from TechNZ and a Growth Services Fund grant from NZTE.

AUT offers KODE Biotech infrastructural support while the university's PhD students have the opportunity to apply their academic skills in a commercial environment.

Ends

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Legendary Bassist David Friesen Plays Wellington’s Newest Jazz Venue

Friesen is touring New Zealand to promote his latest album Another Time, Another Place, recorded live at Auckland's Creative Jazz Club in 2015. More>>

Howard Davis Review: The Father - Descending Into The Depths of Dementia

Florian Zeller's dazzling drama The Father explores the effects of a deeply unsettling illness that affects 62,000 Kiwis, a number expected to grow to 102,000 by 2030. More>>


Howard Davis Review: Blade Runner Redivivus

When Ridley Scott's innovative, neo-noir, sci-fi flick Blade Runner was originally released in 1982, at a cost of over $45 million, it was a commercial bomb. More>>

14-21 October: New Zealand Improv Festival In Wellington

Imagined curses, Shibuya’s traffic, the apocalypse, and motherhood have little in common, but all these and more serve as inspiration for the eclectic improvised offerings coming to BATS Theatre this October for the annual New Zealand Improv Festival. More>>

ALSO:

Bird Of The Year Off To A Flying Start

The competition asks New Zealanders to vote for their favourite bird in the hopes of raising awareness of the threats they face. More>>

Scoop Review Of Books:
Jenny Abrahamson's John & Charles Enys: Castle Hill Runholders, 1864-1891

This volume will be of interest to a range of readers interested in the South Island high country, New Zealand’s natural environment, and the history of science. More>>

 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION